A novel mutation of the WAS gene in a patient with Wiskott-Aldrich syndrome presenting with recalcitrant viral warts

Journal of Dermatological Science

Volumn 60, Issue 2, 2010, Pages 120-122

  Kim, Jin Ki ^a   Yoon, Moon Soo ^a   Huh, Ji Young ^a   Kim, Hee Jin ^b   Kim, Dong Hyun ^a  

^a CHA University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Novel mutation; Warts; WAS gene; Wiskott Aldrich syndrome

Indexed keywords

ETRETIN;

ADULT; CASE REPORT; EXON; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IRON DEFICIENCY ANEMIA; KAPOSI VARICELLIFORM ERUPTION; LETTER; MALE; PAPULE; PRIORITY JOURNAL; RELAPSE; SKIN BIOPSY; THROMBOCYTE TRANSFUSION; VERRUCA VULGARIS; WAS GENE; WISKOTT ALDRICH SYNDROME;

2-AMINOPURINE; ACITRETIN; ADULT; ANTIVIRAL AGENTS; HUMANS; KAPOSI VARICELLIFORM ERUPTION; KERATOLYTIC AGENTS; MALE; MUTATION; WARTS; WISKOTT-ALDRICH SYNDROME;

EID: 77958503612     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.08.007     Document Type: Letter

References (10)

1. Ochs H.D., Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006, 117:725-738.
2. Ochs H.D., Filipovich A.H., Veys P., Cowan M.J., Kapoor N. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant 2009, 15:84-90.
3. Bouma G., Burns S.O., Thrasher A.J. Wiskott-Aldrich syndrome: immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology 2009, 214:778-790.
4. Notarangelo L.D., Miao C.H., Ochs H.D. Wiskott-Aldrich syndrome. Curr Opin Hematol 2008, 15:30-36.
5. Jin Y., Mazza C., Christie J.R., Giliani S., Fiorini M., Mella P., et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004, 104:4010-4019.
6. Sullivan K.E., Mullen C.A., Blaese R.M., Winkelstein J.A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994, 125:876-885.
7. Westerberg L., Larsson M., Hardy S.J., Fernández C., Thrasher A.J., Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 2005, 105:1144-1152.
8. Snapper S.B., Meelu P., Nguyen D., Stockton B.M., Bozza P., Alt F.W., et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 2005, 77:993-998.
9. Tsambaos D., Zimmermann B. Effects of synthetic retinoids on cellular systems. Psoriasis 1991, 659-707. Marcel Dekker, New York. 2nd ed. H.H. Roenigk, H.I. Maibach (Eds.).
10. Zhang C., Duvic M. Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther 2006, 19:264-271.